Search

Find exactly what you’re looking for.
Search

Service
Location
Showing 21-34 of 34 results

IP INSIGHTS: PATENTING IN THE AGE OF ARTIFICIAL INTELLIGENCE (AI) This month, Brian Landry will join Diane Harmon on IP Insights for an exciting session: Patenting in the Age of Artificial Intelligence (AI). Brian and Diane will explore the intersection between AI and patent law, and provide...

SAG-AFTRA Influencer Agreement and Influencer- Produced Sponsored Content Waiver: Key Provisions, New Opportunities Francelina Perdomo Klukosky will lead a presentation on key provisions for influencer agreements and waivers and how to navigate scope and coverage issues.

Francelina Perdomo Klukosky brings extensive experience as an intellectual property attorney to her new role as counsel in the firm. Ms. Perdomo Klukosky focuses on both litigation and transactions for clients in the sports and entertainment industries. She is resident in the New York office. Ms...

Minnesota Appellate Developments – 2022-2023 Midterm Update Katie Barrett Wiik, along with civil and criminal law attorneys from both sides of the caption, will discuss some of the important decisions from the 2022-2023 Term from the Minnesota Supreme Court and the Minnesota Court of Appeals, and...

Saul Ewing Patent Litigators Brian Michalek, Joseph Kuo, Brian Landry, and Courtland Merrill have been invited by the Patent Trial and Appeal Board to participate in a live Stadium Tour Event taking place February 23, 2023 at the Sandra Day O'Connor College of Law, Arizona State University in...

Lukas Pfannenstiel was invited to speak at the US Summit of Laboratory Medicine Innovations conference on January 13th in Houston, TX. The title of his session was "How to Protect Intellectual Property in IVD Research and Development" and focused on the basics of patent protection for academic...

Demystifying International & Interstate Discovery Bill Baton, Vice Chair of the firm's Intellectual Property Practice , will moderate a panel presented by The United States District Court for the District of New Jersey, in conjunction with the Association of the Federal Bar of New Jersey. This...

Kathryn Doyle, a partner at Saul Ewing, will present during the Penn Medicine Commercialization Speaker Series. She will discuss the latest trends in Life Sciences intellectual property on November 17 from 12:00 - 1:00 p.m.

Saul Ewing attorneys hosted this fast-paced webinar, providing a list of things you need to know to develop your checklist for legal issues in 2023, from employment, corporate governance, cybersecurity and privacy, intellectual property to tax. Attorneys with specialized knowledge in these areas...

Kathryn Doyle, Partner at Saul Ewing LLP, will be presenting at the NACUA Annual Meeting, June 26-29, 2022, in Pittsburgh. She will be speaking on June 28, 9:15-10:30 a.m., on the topic "You Thought You Owned It, They Might Have Stolen It, and a Medley of Inventor Kerfuffles”. Joining Kathryn will...

Katherine “Katie” Barrett Wiik brings more than 15 years of experience to her new role as a partner in Saul Ewing’s Litigation and Appellate practices, including serving as lead attorney in dozens of appeals and securing favorable outcomes for clients in cases before the Sixth, Eighth, and Ninth...

Katherine “Katie” Barrett Wiik brings more than 15 years of experience to her new role as a partner in Saul Ewing’s Litigation and Appellate practices, including serving as lead attorney in dozens of appeals and securing favorable outcomes for clients in cases before the Sixth, Eighth, and Ninth...

Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

For More Information
Contact us